UBXN2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.627200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.699200E-01
Normal-vs-Stage2
7.841800E-01
Normal-vs-Stage3
4.113000E-01
Normal-vs-Stage4
3.876800E-01
Stage1-vs-Stage2
5.271800E-01
Stage1-vs-Stage3
4.739600E-01
Stage1-vs-Stage4
3.179400E-01
Stage2-vs-Stage3
1.735560E-01
Stage2-vs-Stage4
5.715400E-01
Stage3-vs-Stage4
9.326300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.887400E-01
Normal-vs-AfricanAmerican
1.078160E-01
Normal-vs-Asian
8.178600E-01
Caucasian-vs-AfricanAmerican
1.477210E-01
Caucasian-vs-Asian
4.967800E-01
AfricanAmerican-vs-Asian
5.098400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.790000E-01
Normal-vs-Female
7.152400E-01
Male-vs-Female
2.335400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.425400E-01
Normal-vs-Age(41-60Yrs)
4.196800E-01
Normal-vs-Age(61-80Yrs)
8.443200E-01
Normal-vs-Age(81-100Yrs)
9.686000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.028600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.976400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.856600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.390190E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.094620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.603800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.876000E-01
Normal-vs-Daily Drinker
7.995200E-01
Normal-vs-Weekly Drinker
8.292600E-01
Normal-vs-Occasional Drinker
7.785000E-01
Normal-vs-Social Drinker
7.124000E-01
Non Drinker-vs-Daily Drinker
5.667800E-01
Non Drinker-vs-Weekly Drinker
7.061400E-01
Non Drinker-vs-Occasional Drinker
6.294600E-01
Non Drinker-vs-Social Drinker
5.170400E-01
Daily Drinker-vs-Weekly Drinker
8.813000E-01
Daily Drinker-vs-Occasional Drinker
3.164000E-01
Daily Drinker-vs-Social Drinker
2.668600E-01
Weekly Drinker-vs-Occasional Drinker
3.906600E-01
Weekly Drinker-vs-Social Drinker
3.257800E-01
Occasional Drinker-vs-Social Drinker
8.343000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.133600E-01
Normal-vs-Grade 2
7.562200E-02
Normal-vs-Grade 3
3.108200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.976200E-02
Grade 1-vs-Grade 3
1.215210E-03
Grade 1-vs-Grade 4
3.133600E-01
Grade 2-vs-Grade 3
2.166100E-02
Grade 2-vs-Grade 4
7.562200E-02
Grade 3-vs-Grade 4
3.108200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.400400E-01
Normal-vs-NonDiabetic
8.748800E-01
Diabetic-vs-NonDiabetic
2.568000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.858800E-01
Normal-vs-NoPancreatitis
9.760800E-01
Pancreatitis-vs-NoPancreatitis
3.359400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.628400E-01
Normal-vs-N1
7.743200E-01
N0-vs-N1
3.983800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.787200E-01
Normal-vs-TP53-NonMutant
8.859800E-01
TP53-Mutant-vs-TP53-NonMutant
6.385800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
